Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABBV
BMY
Add up to 3 more stocks
ABBV
AbbVie Inc.
+0.81%
$257.06+2.06Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$454.17B
52W Range
$190.75 - $267.47
BMY
Bristol-Myers Squibb Company
-0.17%
$63.64-0.11Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$130.00B
52W Range
$42.52 - $68.64
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 72.43 | 14.02 |
| Forward P/E | 18.32 | 9.18 |
| P/B Ratio | N/A | 5.82 |
| P/S Ratio | 7.05 | 2.64 |
| P/FCF Ratio | 25.03 | 11.36 |
| EV/EBITDA | 19.34 | 9.71 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 71.5% | 70.2% |
| Operating Margin | 29.3% | 28.3% |
| Net Margin | 9.8% | 18.9% |
| ROE | N/A | 41.6% |
| ROA | 4.7% | 10.6% |
| ROIC | 13.5% | 15.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 0.81 | 1.53 |
| Quick Ratio | 0.69 | 1.38 |
| Debt/Equity | N/A | 1.93 |
| Interest Coverage | 6.94 | 7.26 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.7% | 3.9% |
| Payout Ratio | 192.4% | 55.3% |
| Yrs of Dividend Growth | 52 | 16 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.